jamssss

After reviewing the challenges faced by the pharmaceutical industry in Indonesia and their efforts to address them through lobbying, it is clear that the industry is grappling with issues related to drug procurement and pricing under the JKN system. The letter to the Minister of Health highlights the significant debt and its impact on providing…[Read more]